PT  - JOURNAL ARTICLE
AU  - Starodub, Alexander
AU  - Henry, Jason
AU  - Vandross, Andrae
AU  - Perez, Cesar
AU  - Spira, Alexander I
AU  - Xu, Yang
AU  - Li, Yuping
AU  - Liao, Xuebin
TI  - 1073 A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of PRJ1–3024in subjects with advanced solid tumors
AID  - 10.1136/jitc-2023-SITC2023.1073
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A1182--A1182
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A1182.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A1182.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.